Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Sitagliptin 100 mg vs JANUVIA 100 mg in Healthy Thai Adults (Fasting, Two-Way Crossover)
TCTR20220401003Phase 1Not yet recruiting
- Sponsor
- Mylan
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of sitagliptin (2 arms), sponsored by Mylan. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
sitagliptin
Beyond the preview
Go deeper on TCTR20220401003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220401003.